A Chronic Neutropenia Study is Now Enrolling
A global clinical research study called the 4WARD Study is now enrolling people living with chronic neutropenia (CN).
The 4WARD Study is a Phase 3 study, or clinical trial. The goal of the 4WARD Study is to learn more about the oral investigative study medicine, mavorixafor. The study will evaluate if mavorixafor may increase neutrophil cell counts, may decrease the chance of getting infections and is safe and well tolerated.
You may be eligible to join the study if you:
- Are age 12 and over
- Are diagnosed with chronic neutropenia (including congenital, acquired primary
- autoimmune, and idiopathic chronic neutropenia)
- Are taking or not taking any treatment for your chronic neutropenia, including granulocyte colony-stimulating factor (G-CSF)
- Meet other study requirements. Talk to your doctor to find out if this study is an option for you.
Chronic neutropenia is a disease with few treatment options. More treatment options are needed. By volunteering to join a study, you can help researchers learn more about chronic neutropenia. Visit 4WARDStudy.com to learn more.
To speak with an X4 Study Nurse please sign up at neutropeniastudy.com.